MedPath

Impact of the COVID-19 Pandemic on the Surgical Activity of Bellvitge University Hospital

Completed
Conditions
Nosocomial Infection
Covid19
Surgery--Complications
Interventions
Procedure: The study evaluates all surgical patients operated, both elective scheduled and emergent cases
Registration Number
NCT04780594
Lead Sponsor
Hospital Universitari de Bellvitge
Brief Summary

COVID-19 has been a challenge for hospitals; there was an obvious need to reconvert many spaces in specific areas to attend this pathology, without forgetting the attention to other pathologies and surgery. The objective of the investigators is to evaluate the impact of this pandemic in the patients who underwent surgery in Bellvitge University Hospital, analyzing 2 periods of time: the months before the COVID-19 peak and the COVID-19 peak months.

Detailed Description

A total of 2.530 procedures have been evaluated in this retrospective observational study. Two groups have been generated (pre-pandemic period and pandemic period), classified into scheduled and emergency surgery. The investigators determined age, type of surgery and specialty, hospital stay, destination at discharge including mortality and severity according to Diagnostic Related to Group (DRG) scale. The investigators have also determined the number of confirmed COVID-19 infections in patients who underwent surgery during these 2 periods and evaluated if the infection was due to a nosocomial infection (confirmation of the COVID-19 during the hospitalization period). Comparisons were made between subgroups: scheduled surgery performed during the 2 periods and emergency surgery performed during the 2 periods.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2530
Inclusion Criteria
  • All surgical patients operated, both elective scheduled and emergent cases
Exclusion Criteria
  • Minor-intermediate surgery that involves discharge from the hospital on the same day of the surgery from the Pre-pandemic period.
  • Procedures related to medical treatment or complications of COVID-19 patients, such as chest tubes, extracorporeal oxygenation or tracheostomy.
  • Those scheduled elective surgery patients in the Covid period that resulted RT-PCR positive, surgery was posponed, were not considered eligible for the analysis.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pandemic COVID-19 group (COVID)The study evaluates all surgical patients operated, both elective scheduled and emergent casesAll patients who underwent surgery from 11th March 2020 until 15th May 2020, which were done during the first wave of the pandemic crisis.
Pre-pandemic COVID-19 group (PreCOVID)The study evaluates all surgical patients operated, both elective scheduled and emergent casesAll patients who underwent surgery from 13th January until 29th February 2020, which are considered free of COVID-19 patients, therefore pre-pandemic period.
Primary Outcome Measures
NameTimeMethod
Register the post-surgical complicationsPreCOVID group from 13th January 2020 to 29th February 2020 and COVID group from 11th March 2020 to 15th May 2020.

Register and Compare the Rate of Surgical Reintervention between both periods.

Secondary Outcome Measures
NameTimeMethod
Register the rate of surgical reinterventionPreCOVID group from 13th January 2020 to 29th February 2020 and COVID group from 11th March 2020 to 15th May 2020.

Register and compare the Rate of reintervention between both periods.

Register the ICU admissionPreCOVID group from 13th January 2020 to 29th February 2020 and COVID group from 11th March 2020 to 15th May 2020.

register and compare the ICU admission between both periods.

Register the Hospital stayPreCOVID group from 13th January 2020 to 29th February 2020 and COVID group from 11th March 2020 to 15th May 2020.

register and compare the ICU admission between both periods.

Register the MortalityPreCOVID group from 13th January 2020 to 29th February 2020 and COVID group from 11th March 2020 to 15th May 2020.

register and compare the Mortality between both periods.

Trial Locations

Locations (1)

Marta Caballero

🇪🇸

Hospitalet de Llobregat, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath